Quinn Opportunity Partners LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 6,500 shares of the healthcare conglomerate's stock, valued at approximately $3,288,000.
Other large investors have also added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the 4th quarter valued at approximately $30,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.
Insider Activity
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.
Analyst Ratings Changes
Several equities analysts have commented on the company. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Truist Financial boosted their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a "buy" rating in a report on Friday. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Piper Sandler lowered their target price on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Finally, StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $632.85.
View Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Down 2.2 %
UNH stock traded down $13.24 during trading on Monday, reaching $586.23. The stock had a trading volume of 4,749,319 shares, compared to its average volume of 4,346,438. UnitedHealth Group Incorporated has a one year low of $438.50 and a one year high of $630.73. The company's 50 day moving average is $512.87 and its two-hundred day moving average is $541.80. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $536.23 billion, a price-to-earnings ratio of 37.82, a P/E/G ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is presently 54.19%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.